Corundum Group Inc. Cuts Stake in Merck & Co., Inc. (NYSE:MR

Corundum Group Inc. lessened its stake in Merck & Co., Inc. (NYSE:MRK – Free Report) by 21.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 9,196 shares of the company’s stock after selling 2,585 shares during the period. Corundum Group Inc.’s holdings in […]

Related Keywords

Societe Generale , Steven Mizell , Joseph Romanelli , Gardasil , Insider Transactions At Merck Co Inc , Merck Co Inc , Wealth Partners , Securities Exchange Commission , Ameliora Wealth Management Ltd , Exchange Commission , Wealth Advisors , Ruedi Wealth Management Inc , Wells Fargo Company , Animal Health , Quarter For Merck Co Inc , Merck Co , Alphamark Advisors , Corundum Group Inc , News Ratings For Merck Co , Corundum Group , Free Report , Wealth Management , Mark Advisors , Ameliora Wealth Management , Truist Financial , Get Free Report , Live Oral , Visit Holdingschannel , Nyse Mrk , Mrk , Medical , 58933y10 , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,